INVARIANT LLC

INVARIANT LLC filed a Q3 report for EGENESIS INC. on October 19, 2025, reporting no lobbying activity.

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

Filing · LD-2 quarterly report Q3 reportNo activity

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Massachusetts

Lobbying activity 0

No itemized activity in this filing.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.